INVESTMENT PROPOSAL
Pharmaceutical Manufacturing Unit – Bahrain
Building a GCC-Focused Pharmaceutical Manufacturing Platform
Investment Opportunity: US$ 8–9 Million Initial Investment
Location: Kingdom of Bahrain
Target Market: Bahrain + GCC + USA Markets
Business Model: Pharmaceutical Manufacturing + GCC & USA Distribution
1. Executive Opportunity
We are planning to establish a modern pharmaceutical manufacturing unit in Bahrain, strategically positioned to serve the growing pharmaceutical requirements of Bahrain and the wider GCC region. The project will combine:
Strong GCC market access and marketing relationships & export to USA
Established relationships with leading pharmaceutical manufacturers in India
Access to proven pharmaceutical manufacturing technology
Technical assistance for plant setup, production, quality systems and operations
Experienced management and commercial support
Our objective is to build a GCC-oriented pharmaceutical manufacturing company in Bahrain, with the capability to manufacture high-quality products competitively and expand the product portfolio over time.
2. Why This Project?
The GCC pharmaceutical market offers an attractive opportunity for a regional manufacturing platform.
Our strategy is simple:
Indian Pharmaceutical Expertise + Bahrain Manufacturing Base + GCC Market Access
Rather than developing the technology and market independently, we intend to leverage established pharmaceutical expertise and relationships from India while building a manufacturing and commercial presence in Bahrain.
This significantly reduces technology and execution risk.
3. Our Key Strengths
MARKET ACCESS
The promoters have strong business contacts and relationships across GCC markets, providing a foundation for product marketing, distribution and commercial development.
TECHNOLOGY & TECHNICAL SUPPORT
We have strong relationships with leading pharmaceutical manufacturing companies in India that can support:
Manufacturing technology
Product development
Plant design and technical guidance
Production systems
Quality management
Regulatory and documentation support
Training of technical personnel
Operational assistance during commissioning and production
MANAGEMENT & EXECUTION
The project will be driven by a team combining pharmaceutical industry relationships, manufacturing knowledge and GCC commercial networks, This combination provides an important advantage:
we are approaching the project with both the manufacturing side and the market side already developed.
4. Proposed Business Model
The Bahrain facility will initially focus on selected pharmaceutical products with strong commercial potential in Bahrain , GCC and USA markets.
The business will operate through:
Manufacturing in Bahrain
↓
Regulatory & Quality Compliance
↓
Bahrain Market
↓
GCC Distribution Network
↓
Expansion into Additional GCC Markets
The product portfolio can be expanded progressively based on market demand, regulatory approvals and commercial performance.
5. Investment Requirement
Initial Project Investment: US$ 8–9 Million
The investment will be utilized for:
Manufacturing facility and infrastructure
Pharmaceutical production equipment
Quality-control and laboratory facilities
Utilities and supporting systems
Technology transfer and technical assistance
Regulatory and registration activities
Initial working capital
Recruitment and training
Product development and launch
Initial GCC marketing and distribution
A detailed financial model, CAPEX/OPEX plan and implementation schedule will be presented during the investor due-diligence stage.
6. Why Invest With Us?
The project offers an investor the opportunity to participate in a pharmaceutical manufacturing platform designed specifically for the GCC market.
The major value proposition is the combination of:
1. Bahrain manufacturing base
2. Indian pharmaceutical technology and expertise
3. Existing GCC commercial relationships
4. Scalable product portfolio
5. Regional expansion potential
Our intention is not simply to establish a manufacturing plant, but to create a long-term GCC pharmaceutical business capable of expanding products, markets and manufacturing capacity.
7. Partnership Opportunity
We are seeking a strategic investor / investment partner for the initial project investment of approximately US$ 8–9 million.
The investment structure, equity participation, management responsibilities and investor returns can be discussed and finalized based on the investor's requirements and the project's final financial model.
OUR VISION
“To establish Bahrain as a competitive pharmaceutical manufacturing and distribution base serving the GCC.”
We believe the project has the potential to develop into a regional pharmaceutical platform, combining Indian manufacturing expertise with Bahrain's strategic position and our GCC market relationships.
We are now looking for the right strategic investor to build this opportunity together.
Investment Required: US$ 8-9 Million
Next Step: Detailed business plan, product portfolio, CAPEX, financial projections, implementation schedule and proposed investment structure will be shared with interested investors.